SeQure Dx empowers assessment of on and off-target editing for gene editing therapeutics.
Location: United States, Massachusetts, Waltham
Total raised: $17.5M
Investors 2
| Date | Name | Website |
| - | KdT Ventur... | kdtvc.com |
| 07.08.2021 | Digitalis ... | digitalisv... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.08.2021 | Series A | $17.5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 04.08.2021 | SeQure Dx lands $17.5M | SeQure Dx has raised a $17.5 million Series A co-led by RiverVest Venture Partners and Mass General Brigham Ventures. Based in the Boston area, the company is a developer of gene-editing diagnostic technologies intended for use in drug deve... |
| 03.08.2021 | SeQure Dx Scoops Up $17.5M Series A Funding | WALTHAM, MA, SeQure Dx, a gene-editing diagnostics company, announced today a $17.5 million Series A funding round. >> Click here for more funding data on SeQure Dx >> To export SeQure Dx funding data to PDF and Excel, click... |
| 03.08.2021 | SeQure Dx : Announces $17.5M Series A Funding | SeQure Dx, a gene-editing diagnostics company, announced today a $17.5 million Series A funding led by RiverVest Venture Partners and Mass General Brigham Ventures along with Digitalis Ventures, Casdin Capital, KdT Ventures, Bold Capital Pa... |
| 03.08.2021 | SeQure Dx Raises $17.5M in Series A Funding | SeQure Dx, a Waltham, Mass.-based gene-editing diagnostics company, raised $17.5m in Series A funding. The round was led by RiverVest Venture Partners and Mass General Brigham Ventures with participation from Digitalis Ventures, Casdin Capi... |